Amgen Wins FDA Approval For Skin Cancer Drug
October 28, 2015 at 08:04 AM EDT
Amgen states that this drug will be available on the market within one week, and that treatment would cost around $65,000. This approval was made possible to a late-stage phase 3 study known as the OPTiM study.
